Integrating non-drug treatments in early schizophrenia

British Journal of Psychiatry

Volumn 187, Issue SUPPL. 48, 2005, Pages

  Lewis, Shôn W ^a   Tarrier, Nicolas ^a   Drake, Richard J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CANNABIS; CLOZAPINE; HALOPERIDOL; OLANZAPINE; PLACEBO; RISPERIDONE; NEUROLEPTIC AGENT;

BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; DRUG MISUSE; FAMILY; HUMAN; MOTIVATION; PATIENT COMPLIANCE; PROGNOSIS; RELAPSE; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SYMPTOM; TREATMENT OUTCOME; ARTICLE; FAMILY THERAPY; METHODOLOGY; RECURRENT DISEASE;

ANTIPSYCHOTIC AGENTS; COGNITIVE THERAPY; FAMILY THERAPY; HUMANS; PATIENT COMPLIANCE; RECURRENCE; RISK FACTORS; SCHIZOPHRENIA;

EID: 23844480427     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.187.48.s65     Document Type: Review

References (68)

1. American Psychiatric Association (2004) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). Washington, DC: APA.
2. Amminger, G. P., Edwards, J., Brewer, W. J., et al (2002) Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia. Schizophrenia Research, 54, 223-230.
3. Arseneault, L., Cannon, M., Poulton, R., et al (2002) Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ, 23, 212-213.
4. Barrowclough, C., Tarrier, N., Lewis, S., et al (1999) Randomised controlled effectiveness trial of a needs-based psychosocial intervention service for carers of people with schizophrenia. British Journal of Psychiatry, 174, 505-511.
5. Barrowclough, C., Haddock, G., Tarrier, N., et al (2001) Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry, 158, 706-713.
6. Bilder, R. M., Lipschutz, L. B., Reiter, G., et al (1992) Intellectual deficits in first episode schizophrenia: evidence for progressive deterioration. Schizophrenia Bulletin, 18, 437-448.
7. Bilder, R. M., Goldman, R. S., Robinson, D., et al (2000) Neuropsychology of first episode schizophrenia: initial characterization and clinical correlates. American Journal of Psychiatry, 157, 549-559.
8. Brenner, H., Roder, V., Hodel, B., et al (1994) Integrated Personal Therapy for Schizophrenia Patients. Toronto, Canada: Hogrefe & Huber.
9. Buckley, P. F., Noffsinger, S. G., Smith, D. A., et al (2003) Treatment of the psychotic patient who is violent. Psychiatric Clinics of North America, 26, 231-272.
10. Byrne, M., Hodges, A., Grant, E., et al (2000) Neuropsychological assessment of young people at high genetic risk for schizophrenia compared with controls: results preliminary findings from the Edinburgh High Risk Study. Psychological Medicine, 29, 1161-1173.
11. Butzlaff, R. L. & Hooley, J. M. (1998) Expressed emotion and psychiatric relapse: a meta-analysis. Archives of General Psychiatry, 55, 547-552.
12. Cosway, R., Byrne, M., Clafferty, R., et al (2000) Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study. Psychological Medicine, 30, 1111-1121.
13. Drake, R. E. & Mueser, K. T. (2001) Substance abuse comorbidity. In Comprehensive Care of Schizophrenia. A Textbook of Clinical Management (eds J. A. Lieberman & R. M. Murray). London: Martin Dunitz.
14. Drake, R. J. & Lewis, S. W. (2003) Insight and neurocognition in acute schizophrenia and related disorders. Schizophrenia Research, 62, 165-173.
15. Drake, R. J., Haley, C. J., Akhtar, S., et al (2000) Causes and consequences of duration of untreated psychosis in schizophrenia. British Journal of Psychiatry, 177, 511-515.
16. Drake, R. E., Xie, H., McHugo, G. J., et al (2000) The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophrenia Bulletin, 26, 441-449.
17. Erlenmeyer-Kimling, L., Rock, D., Roberts, S. A., et al (2000) Attention, memory and motor skills as childhood predictors of schizophrenia related psychoses: the New York High Risk Project. American Journal of Psychiatry, 157, 1416-1422.
18. Gaebel, W., Janner, M., Frommann, N., et al (2002) First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies. Schizophrenia Research, 53, 145-159.
19. Goldstein, M. J. (1996) Psycho-education and family treatment related to the phase of psychiatric disorder. International Clinical Psychopharmacology, II (suppl. 2), s77-s83.
20. Green, M. F. (1996) What are the functional consequences of the neurocognitive deficits in schizophrenia? American Journal of Psychiatry, 153, 321-330.
21. Gumley, A., O'Grady, M., McNay, L., et al (2003) Early intervention for relapse in schizophrenia: results of a 12 month randomised controlled trial of CBT. Psychological Medicine, 33, 419-431.
22. Haddock, G., Barrowclough, C., Tarrier, N., et al (2003) Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18-month outcomes of a randomised controlled trial. British Journal of Psychiatry, 183, 418-426.
23. Hans, S. L., Marcus, J., Nuechterlein, K. H., et al (1999) Neurobehavioural deficits at adolescence in children at risk for schizophrenia. The Jerusalem infant development study. Archives of General Psychiatry, 56, 741-748.
24. Harrigan, S. M., McGorry, R D. & Krstev, H. (2003) Does treatment delay in first-episode psychosis really matter? Psychological Medicine, 33, 97-110.
25. Ho, B. C., Alicata, D., Ward, J., et al (2003) Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. American Journal of Psychiatry, 160, 142-148.
26. Hogarty, G. E., Greenwald, D., Ulrich, R. F., et al (1997a) Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: effects on adjustment of patients. American Journal of Psychiatry, 154, 1514-1524.
27. Hogarty, G. E., Kornblith, S. J., Greenwald, D., et al (1997b) Three-year trials of personal therapy among schizophrenic patients living with or independent of family: I, description of study and effects on relapse rates. American Journal of Psychiatry, 154, 1504-1513.
28. Hutton, S. B., Puri, B. K., Duncan, L. J., et al (1998) Executive function in first episode schizophrenia. Psychological Medicine, 28, 463-473.
29. Joyce, E., Hutton, S., Mutsatsa, S., et al (2002) Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: the West London Study. British Journal of Psychiatry, 181 (suppl. 43), s38-s44.
30. Kay, S. R., Fiszbein, A. & Opler, L. A. (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-267.
31. Kemp, R., Hayward, P., Applethwaite, G., et al (1996) Compliance therapy in psychotic patients: randomised controlled trial. BMJ, 312, 345-349.
32. Kemp, R., Kirov, G., Everitt, B., et al (1998) Randomised controlled trial of compliance therapy: 18-month follow-up. British Journal of Psychiatry, 172, 413-419.
33. Kuipers, E., Garety, P., Fowler, D., et al (1997) The London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I: Effects of the treatment phase. British Journal of Psychiatry, 171, 319-327.
34. Kuipers, E., Bebbington, P., Pilling, S., et al (1999) Family intervention in psychosis: who needs it? Epidemiologia e Psichiatria Sociale, 8, 169-173.
35. Lenior, M. E., Dingemans, P. M., Linszen, D. H., et al (2001) Social functioning and the course of early-onset schizophrenia: five year follow-up of a psychosocial intervention. British Journal of Psychiatry, 179, 53-58.
36. Lewis, S., Tarrier, N., Haddock, G., et al (2002) Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes. British Journal of Psychiatry, 181 (suppl. 43), s91-s97.
37. Linszen, D. H., Dingemans, P. M. & Lenior, M. E. (1994) Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry, 51, 273-279.
38. McFarlane, W. R., Lukens, E., Link, B., et al (1995) Multiple family groups and psychoeducation in the treatment of schizophrenia. Archives of General Psychiatry, 52, 679-687.
39. McGorry, P. D., Yung, A. R., Phillips, L. J., et al (2002) Randomised controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry, 59, 921-928.
40. Mohamed, S., Paulsen, J. S., O'Leary, D., et al (1999) Generalized cognitive deficits in schizophrenia. A study of first episode patients. Archives of General Psychiatry, 56, 749-754.
41. Mojtabai, R., Bromet, E. J., Harvey, P. D., et al (2000) Neuropsychological differences between first-admission schizophrenia and psychotic affective disorders. American Journal of Psychiatry, 157, 1453-1460.
42. Morrison, A. P., Bentall, R. P., French, P., et al (2002) Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high risk individuals: Study design and interim analysis of transition rate and psychological risk factors. British Journal of Psychiatry, 181 (suppl. 43), 78-84.
43. Mueser, K.T. & Berenbaum, H. (1990) Psychodynamic treatment of schizophrenia: is there a future? Psychological Medicine, 20, 253-262.
44. Norman, R. M. G., Lewis, S.W. & Marshall, M. (2005) Duration of untreated psychosis and its relationship to clinical outcome. British Journal of Psychiatry, 187 (suppl. 48), s19-s23.
45. Pharoah, F. M., Mari, J. J. & Streiner, D. (2003) Family intervention for schizophrenia. Cochrane Database of Systematic Reviews, (2), CD000088.
46. Pilschel-Walz, G., Leucht, S., Bauml, J., et al (2001) The effect of family interventions on relapse and rehospitalisation in schizophrenia - a meta-analysis. Schizophrenia Bulletin, 27, 73-92.
47. Remington, G., Kapur, S. & Zipursky, R. B. (1998) Pharmacotherapy of first-episode schizophrenia. British Journal of Psychiatry, 172 (suppl. 33), s66-s70.
48. Riley, E. M., McGovern, D., Mockler, D., et al (2000) Neuropsychological functioning in first episode psychosis - evidence of specific deficits. Schizophrenia Research, 43, 47-55.
49. Rosenheck, R., Tekell, J., Peters, J., et al (1998) Does participation in psychosocial treatment augment the benefit of clozapine? Archives of General Psychiatry, 55, 618-625.
50. Rund, B. R. (1998) A review of longitudinal studies of cognitive functions in schizophrenia patients. Schizophrenia Bulletin, 24, 425-435.
51. Scully, P. J., Coakley, G., Kinsella, A., et al (1997) Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated vs subsequently treated psychosis in chronic schizophrenia. Psychological Medicine, 27, 1303-1310.
52. Sellwood, W., Barrowclough, C., Tarrier, N., et al (2001) Needs-based cognitive-behavioural family intervention for carers of patients suffering from schizophrenia: 12-month follow-up. Acta Psychiatrica Scandinavica, 104, 346-355.
53. Sensky, T., Turkington, T., Kingdon, D., et al (2000) A randomised, controlled trial of cognitive behaviour therapy for persistent positive symptoms in schizophrenia resistant to medication. Archives of Generaly Psychiatry, 57, 165-173.
54. Stirling, J., White, C., Lewis, S., et al (2003) Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort. Schizophrenia Research, 15, 65, 75-86.
55. Tarrier, N. & Calam, R. (2002) New developments in cognitive behavioural therapy case formulation: epidemiological, systemic and social context: an integrative approach. Behavioural and Cognitive Psychotherapy, 30, 311-328.
56. Tarrier, N., Sharpe, L., Beckett, R., et al (1993) A trial of two cognitive behavioural methods of treating drug-reistant residual psychotic symptoms in schizophrenic patients: II. Treatment-specific changes in coping and problem-solving skills. Social Psychiatry and Psychiatric Epidemiology, 28, 5-10.
57. Tarrier, N., Yusopoff, L., Kinney, C., et al (1998) Randomised controlled trial of intensive cognitive behavioural therapy for patients with chronic schizophrenia. BMJ, 317, 303-307.
58. Tarrier, N., Lewis, S., Haddock, G., et al (2004) Cognitive-behavioural therapy in first-episode and early schizophrenia: 18-month follow-up of a randomised controlled trial. British Journal of Psychiatry, 184, 231-239.
59. Turkington, D., Kingdon, D., Turner, T., et al (2002) Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry, 180, 523-527.
60. Vaughn, C. E. & Left, J. P. (1976) The influence of family and social factors on the course of psychiatric illness. A comparison of schizophrenic and depressed neurotic patients. British Journal of Psychiatry, 129, 125-137.
61. Verdoux, H., Lengronne, J., Liraud, F., et al (2000) Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects. Acta Psychiatrica Scandnavica, 102, 203-210.
62. Viksman, P., Poyurovsky, M., Balush, V., et al (2002) Metacognition in first episode schizophrenia: its relationship to theory of mind and executive functioning. Schizophrenia Research, 53, 137.
63. Wahlbeck, K., Tuunainen, A., Gilbody, S., et al (2000) Influence of methodology on outcomes of randomised clozapine trials. Pharmacopsychiatry, 33, 54-59.
64. Woods, S.W., Breier, A., Zipursky, R. B., et al (2003) Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biological Psychiatry, 54, 453-564.
65. Wykes, T., Reeder, C., Corner, J., et al (1999) The effects of neurocognitive remediation on executive processing in patients with schizophrenia. Schizophrenia Bulletin, 25, 291-307.
66. Wykes, T., Reeder, C., Williams, C., et al (2003) Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial. Schizophrenia Research, 61, 163-174.
67. Yung, A., Phillips, L. J., McGorry, P. D., et al (1998) Prediction of psychosis. A step towards indicated prevention of schizophrenia. British Journal of Psychiatry, 172 (suppl. 33), s14-s20.
68. Zammit, S., Allebeck, P., Andreasson, S., et al (2002) Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ, 325, 1183-1184.